Keyphrases
Indonesia
100%
Indonesian
39%
Transmembrane
34%
Primaquine
34%
Prostate
34%
Androgens
34%
Triple-negative Breast Cancer Cells
29%
Clinical Trials
27%
Acute Lymphoblastic Leukemia
25%
Plasma Concentration
23%
Jakarta
23%
Indonesian Population
22%
Genotype
22%
Falciparum Malaria
21%
Cytochrome P450 2D6 (CYP2D6)
20%
Type 2 Diabetes Mellitus (T2DM)
20%
Hydroxylation
20%
Pada
20%
Postmenopausal Women
20%
Hematotoxicity
20%
Plasminogen Activator inhibitor-1 (PAI-1)
20%
Endophthalmitis
20%
Randomized Controlled Trial
19%
Clinical Response
19%
6-mercaptopurine (6-MP)
18%
High-performance Liquid Chromatography
18%
Amikacin
18%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
16%
Rifampicin
16%
Doxorubicin
16%
Intravitreal
16%
Randomized Clinical Trial
15%
Rat Plasma
15%
Pediatric
15%
Healthy Volunteers
15%
Maintenance Therapy
14%
Human Plasma
14%
Pseudomonas Aeruginosa (P. aeruginosa)
14%
Butyrylcholinesterase (BChE)
13%
Neonate
13%
Steroid Response
13%
Mephenytoin
13%
Isoflavone Supplementation
13%
Granulocyte Colony-stimulating Factor (G-CSF)
13%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
13%
Kidney Injury molecule-1 (KIM-1)
13%
Soy Isoflavones
13%
Carbamazepine
13%
Osteopenia
13%
Clopidogrel Resistance
13%
Pharmacology, Toxicology and Pharmaceutical Science
Primaquine
34%
Randomized Controlled Trial
33%
Clinical Trial
31%
Acute Lymphoblastic Leukemia
24%
Normal Human
22%
Plasmodium Vivax Malaria
21%
Pharmacokinetics
21%
Triple Negative Breast Cancer
20%
Isoniazid
20%
Endophthalmitis
20%
Blood Toxicity
20%
Androgen
20%
Combination Therapy
19%
Mercaptopurine
19%
Chemotherapy
17%
Amikacin
17%
Rifampicin
16%
Doxorubicin
16%
High Performance Liquid Chromatography
15%
Drug Interaction
15%
Pseudomonas aeruginosa
14%
Ritonavir
13%
Granulocyte Colony Stimulating Factor
13%
Melatonin
13%
Clopidogrel
13%
CYP2D6
13%
Kidney Injury Molecule 1
13%
Mouth Squamous Cell Carcinoma
13%
Carbamazepine
13%
Proguanil
13%
Levofloxacin
13%
Non Insulin Dependent Diabetes Mellitus
13%
Plasminogen Activator Inhibitor 1
13%
Cross-Sectional Study
13%
Malignant Neoplasm
12%
Decompensated Liver Cirrhosis
11%
Cisplatin
11%
Side Effect
11%
Infection
10%
Gentamicin
10%
Cycloguanil
10%
Prevalence
10%
Creatinine
10%
Randomized Clinical Trial
9%
Leporidae
9%
Placebo
9%
Bioavailability
9%
Proctitis
9%
Paclitaxel
9%
P-Glycoprotein
9%